Skip to main content

JAMS ADR Insights

Life Sciences & Biotechnology Neutral Evaluation/Analysis

The Value of Using Neutral Analysis in Life Sciences Disputes

Imagine that you have multiple published and peer-reviewed clinical trials and time is of the essence to get your vaccine to market. Unfortunately, you are involved in a lawsuit for patent infringement with a competitor. Will you go to trial? What are your odds of prevailing?

Open in new window

PharmaVoice


Disclaimer:
This page is for general information purposes. JAMS makes no representations or warranties regarding its accuracy or completeness. Interested persons should conduct their own research regarding information on this website before deciding to use JAMS, including investigation and research of JAMS neutrals. See More

Scroll to top